Breast cancer (BC) is the most common cancer and the second leading cause of cancer death in women. It is a highly variable ...
9hon MSN
An off-the-shelf immunotherapy for targeting solid tumors: Ready-to-use CAR-NKT cells show promise
A UCLA research team has identified the best design for a promising new type of immunotherapy that could be mass-produced to treat multiple solid tumors. The study focused on engineered invariant ...
University of Queensland researchers who mapped cancer cell "neighborhoods" in the most common type of lung cancer have found ...
Engineered yeast cells can mimic real cancer cells and be used to test new cancer immunotherapies much faster, benefiting patients.
A new generation of engineered immune cell destroys cancer cells in mice 1 as effectively as conventional CAR-T-cell ...
Researchers have found a reliable way to grow helper T cells from stem cells, solving a major challenge in immune-based cancer therapy. Helper T cells act as the immune system’s coordinators, helping ...
Receiving a diagnosis of squamous cell carcinoma (SCC) can be an overwhelming experience, but it is important to remember ...
Stem Cell Therapy for Cancer Treatment - As life expectancies increase and lifestyle diseases become more common, preserving stem cells offers valuable insurance against future health challenges.
Researchers have uncovered a stealthy way pancreatic cancer disarms the immune system, using tiny molecular messengers to ...
SurvivorNet on MSN
Could timing give your cancer treatment a boost? New study on the best time to receive immunotherapy & chemo for non-small cell lung cancer
A new randomized clinical trial showed that receiving immunochemotherapy infusions earlier in the day may help patients with ...
February marks Cancer Prevention Month. Research shows lifestyle change and early detection can make a big difference in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results